Written by : Nikita Saha
April 5, 2025
Joining Khurana at the helm is Dr Shravan Subramanyam, who has been appointed as the Managing Director of BPL Medical.
In a strategic leadership reshuffle aimed at accelerating its growth trajectory, BPL Medical Technologies has announced a series of high-profile appointments, positioning itself to become India’s first billion-dollar MedTech company.
Sunil Khurana, who has served as the company’s Managing Director and CEO, has been promoted to Executive Chairman.
With over a decade at BPL Medical, Khurana has played a pivotal role in transforming the company’s MedTech footprint. He joined BPL from Bharti Infratel, and prior to that, held senior leadership roles including Director-CT at GE Healthcare. He is a graduate of NIT Warangal with a B.Tech in Electrical Engineering.
Joining him at the helm is Dr Shravan Subramanyam, who has been appointed as the Managing Director of BPL Medical.
Dr Subramanyam brings with him over two decades of experience in medical devices and life sciences, having previously served as President & CEO of GE Healthcare – South Asia and Managing Director of Wipro GE Healthcare from October 2020 to February 2023. Most recently, he headed the Medical Technology Platform at Claypond Capital.
In another key move, Guruswamy K, MBE, who served as Chief Operating Officer, has now been promoted to CEO.
A seasoned leader in the global MedTech space, Guruswamy is also a Member of the Order of the British Empire (MBE) a prestigious title conferred by the Late Queen Elizabeth II in recognition of his contributions during his tenure as CEO at Penlon, UK in 2020.
“The strong leadership team is poised for BPL to be India’s first billion-dollar MedTech company,” the company stated.
The new leadership structure reflects BPL’s growing ambition in the Indian and global MedTech markets, as it doubles down on innovation, global expansion, and strategic investments.